Companies · Financials · 🇺🇸

Elevance Health

ELV · NYSE/NASDAQ · Financials · $386 a share (close of 02 Oct 2026)

Available company data, source links and archived checks for Elevance Health. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Revenue rose 1.4%; Net profit was $1.46 billion.

Quarter ended 2026-06-30 · consolidated · Company filing

Recorded quarterly figures
QuarterRevenue / incomeYoY ProfitYoYNet marginSource
Jun 2026Revenue: $50.5 bn+1.4%Net profit: $1.5 bn-16.1%2.9%Company filing source
Mar 2026Revenue: $50.2 bn+2.6%Net profit: $1.8 bn-19.4%3.5%Company filing source
Dec 2025Revenue: $49.7 bn+9.5%Net profit: $547 mn+30.9%1.1%Company filing source
Sep 2025Revenue: $50.7 bn+12.4%Net profit: $1.2 bn+17.0%2.3%Company filing source
Jun 2025Revenue: $49.8 bn+13.4%Net profit: $1.7 bn-24.3%3.5%Company filing source
Mar 2025Revenue: $48.9 bn+14.8%Net profit: $2.2 bn-2.9%4.5%Company filing source

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

Recently checked facts

(In Millions, Except As Otherwise Stated Herein)

As a result of our investing and borrowing activities, we are exposed to financial market risks, including those resulting from changes in interest rates and changes in market valuations. Potential impacts discussed below are based upon sensitivity analyses performed on our financial position as of December 31, 2025. Actual results could vary from these estimates. Our primary objectives with our investment portfolio are to provide safety and preservation of capital, sufficient liquidity to meet cash flow requirements, the integration of investment strategy with the business operations and an attainment of a competitive after-tax total return.

✓ verified by reading the document archived check · 2026-09-15 SEC filing →

A Privacy and Security Incident Response and Reporting Policy and Procedure with escalation criteria supports response and disclosure.

✓ verified by reading the document archived check · 2026-09-15 SEC filing →

A significant portion of business comes from mergers, acquisitions, joint ventures, strategic alliances and investments.

✓ verified by reading the document archived check · 2026-09-15 SEC filing →

A summary of the cash dividend activity for the years ended December 31, 2025 and 2024 is as follows:

Table extract · original text

Column boundaries are incomplete. Use the source document to interpret these figures.

| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Declaration Date | | Record Date | | Payment Date | | Cash Dividend
per Share | | Total
| Year ended December 31, 2025 | | | | | |
| January 22, 2025 | | March 10, 2025 | | March 25, 2025 | | $ | 1.71 | | | $ | 386 |
| April 16, 2025 | | June 10, 2025 | | June 25, 2025 | | 1.71 | | | 385 |
| July 16, 2025 | | September 10, 2025 | | September 25, 2025 | | 1.71 | | | 381 |
| October 15, 2025 | | December 5, 2025 | | December 19, 2025 | | 1.71 | | | 377 |
| | | | | | | | |
| Year ended December 31, 2024 | | | | | |
| January 23, 2024 | | March 8, 2024 | | March 22, 2024 | | $ | 1.63 | | | $ | 379 |
| April 16, 2024 | | June 10, 2024 | | June 25, 2024 | | 1.63 | | | 378 |
| July 16, 2024 | | September 10, 2024 | | September 25, 2024 | | 1.63 | | | 378 |
| October 15, 2024 | | December 5, 2024 | | December 20, 2024 | | 1.63 | | | 373 |

On January 27, 2026, our Audit Committee declared a quarterly cash dividend to shareholders of $1.72 per share on the outstanding shares of our common stock. This quarterly dividend is payable on March 25, 2026 to the shareholders of record as of March 10, 2026.

✓ verified by reading the document archived check · 2026-09-15 SEC filing →

ASU 2023-07 became effective for our fiscal year beginning after December 15, 2023, and for interim periods within our fiscal year beginning after December 15, 2024. We adopted these amendments on January 1, 2024, using the retrospective approach. Accordingly, the amendments were applied to all prior periods presented in the financial statements, and significant segment expense categories and amounts for prior periods are based on the categories identified and disclosed in the period of adoption. The adoption of ASU 2023-07 did not have an impact on our results of operations or our consolidated cash flows.

✓ verified by reading the document archived check · 2026-09-15 SEC filing →
Who holds it — from the filings
BlackRock, Inc.VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORPWELLINGTON MANAGEMENT GROUP LLPFirst Eagle Investment Management, LLCregister as filed 2026-08-31
Filing timeline — what the company told the exchange

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time
Or just the free morning: three facts checked against filings, every trading day, in your inbox.

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances